Quest Diagnostics Inc QDI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $137.00
- Day Range
- $137.95–137.95
- 52-Week Range
- —–138.85
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $15.36 Bil
- Volume/Avg
- 0 / 11
Key Statistics
- Price/Earnings (Normalized)
- 16.92
- Price/Sales
- 1.78
- Dividend Yield (Trailing)
- 1.98%
- Dividend Yield (Forward)
- 1.97%
- Total Yield
- 3.63%
Company Profile
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Value
- Total Number of Employees
- 48,000
- Website
- https://www.questdiagnostics.com
Competitors
Valuation
|
Metric
|
QDI
|
SHL
|
MYGN
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.92 | 25.75 | 522.41 |
Price/Book Value | 2.47 | 1.62 | 3.22 |
Price/Sales | 1.78 | 1.42 | 2.85 |
Price/Cash Flow | 11.74 | 11.88 | — |
Price/Earnings
QDI
SHL
MYGN
Financial Strength
|
Metric
|
QDI
|
SHL
|
MYGN
|
|---|---|---|---|
Quick Ratio | 0.79 | 0.86 | 1.44 |
Current Ratio | 1.00 | 1.01 | 1.96 |
Interest Coverage | 7.01 | 4.49 | −48.66 |
Quick Ratio
QDI
SHL
MYGN
Profitability
|
Metric
|
QDI
|
SHL
|
MYGN
|
|---|---|---|---|
Return on Assets (Normalized) | 7.23% | 3.75% | 0.46% |
Return on Equity (Normalized) | 15.53% | 6.67% | 0.70% |
Return on Invested Capital (Normalized) | 9.63% | 4.07% | 0.67% |
Return on Assets
QDI
SHL
MYGN
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Wfdgjhsls | Qtx | $236.6 Bil | |||
| Danaher Corp
DHR
| Prfpwbhyh | Jznchl | $200.0 Bil | |||
| IQVIA Holdings Inc
IQV
| Fbdsbbk | Skxbd | $43.1 Bil | |||
| Agilent Technologies Inc
A
| Kcsdpgmcp | Gvdm | $42.2 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Lbvfkdklkr | Lbrg | $41.9 Bil | |||
| Mettler-Toledo International Inc
MTD
| Wygxtwyb | Yhnpwnq | $31.6 Bil | |||
| Icon PLC
ICLR
| Mtkkszjq | Wycrddt | $23.7 Bil | |||
| Waters Corp
WAT
| Xcgjzgdjf | Wgpn | $21.1 Bil | |||
| Illumina Inc
ILMN
| Tzwfzlyt | Nljvh | $21.1 Bil | |||
| Labcorp Holdings Inc
LH
| Vqhgtpvsr | Gzdgwj | $18.5 Bil |
United States